PriceTracker GLP-1

GLP-1 TV · Clinician · views checked Oct 2026

Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)

ClinicianDr. Kevin Joseph, DO945,916 views14:52Jun 2026

Our summary

A clinician (DO) explains how Ozempic works and what the evidence says, mentioning 1 mg, 4 mg and 9 mg. Also covers food noise and cravings, stopping and maintenance and the trials.

General education as published by the channel. Not medical advice, and not an endorsement.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 The case for retatrutide
  2. 1:00 Mechanism of action
  3. 2:10 How the three switches work
  4. 4:08 Weight loss clinical results
  5. 5:14 Impact on liver health
  6. 8:31 Joint health and mobility
  7. 10:11 Cardiovascular and lipid data
  8. 11:12 Kidney and respiratory health

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, semaglutide, tirzepatide and retatrutide
Doses mentioned
1 mg, 4 mg and 9 mg
Who is speaking
Clinician, DO (Dr. Kevin Joseph)

Find more like it

Dose changeWeigh-in and resultsFood noise and cravingsStopping and maintenanceHow it worksThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV